The scientific opportunities identified in the 2011 NICHD Vision Workshop on Reproduction included the need for innovative and safer methods of contraception. Combined hormonal contraceptive methods have been used for more than 50 years and are very effective if used as directed, but failures occur due to incorrect use. Several factors may contribute to irregular use: (1) Concerns about ethinyl estradiol (EE), the synthetic estrogen in most formulations, which is associated with an increased risk of a venous thromboembolism (VTE) as well as nausea and headache. (2) The need for daily attention. Despite the availability of many contraceptive options, the need for innovative contraceptive methods allowing improved compliance is real. In addition, little is known on the effects of contraceptives on the brain, although recent literature showed a neuroprotective, neuroregenerative and promyelinating effect of some, but not all molecules used for contraception in young women. Nestorone? (NES), a nonandrogenic progestin currently developed for contraception has also been shovm to have potential beneficial outcomes in inducing and sustaining the regenerative capacity of the brain and also in stimulating the myelin repair in animal models. We propose to develop a novel, user-controlled semi long-acting contraceptive method to address the safety issues surrounding the use of EE as well as the compliance problems related to the need for frequent user attention. This method consists of a vaginal ring delivering 17beta-estradiol (E2), a natural estrogen not associated with increased VTE risk, plus NES, a progestin with potential benefits. The vaginal ring is designed to be used continuously for 3 months. In parallel with an initial clinical study of the NES/E2 vaginal ring, research will be conducted on regenerative capacity of the brain and promyelinating effects of NES + E2 in cell systems and validated animal models at contraceptive doses. This multidisciplinary proposal is consistent with goals identified in the 2011 NICHD Scientific Vision Workshops on Reproduction and Plasticity. Should the results continue to be positive, further research would include clinical evaluation of the NES/E2 ring as a potential safer contraceptive with additional activity (promyelinating effects) for women with multiple sclerosis and/or with a positive effect on the cognitive function.

Public Health Relevance

A novel user-controlled contraceptive vaginal ring (CVR) with potential improvements in safety and ease of use will be developed. Each 3-month ring will deliver natural estradiol (E2), having less of the side effects associated with synthetic estrogens, and a non-androgenic progestin (Nestorone?, NES). Potential benefits of E2 and NES on the brain will be tested in animals and may lead to clinical benefits on cognitive function and mvtilin repair.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZHD1-DRG-H)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Population Council
New York
United States
Zip Code
El-Etr, Martine; Rame, Marion; Boucher, Celine et al. (2015) Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia 63:104-17
Huang, YongMei; Jensen, Jeffrey T; Brache, Vivian et al. (2014) A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception. Contraception 90:565-74
Mok, Ka-Wai; Mruk, Dolores D; Cheng, C Yan (2014) rpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9. J Cell Sci 127:4870-82
Xiao, Xiang; Mruk, Dolores D; Wong, Chris K C et al. (2014) Germ cell transport across the seminiferous epithelium during spermatogenesis. Physiology (Bethesda) 29:286-98
Xiao, Xiang; Mruk, Dolores D; Tang, Elizabeth I et al. (2014) N-wasp is required for structural integrity of the blood-testis barrier. PLoS Genet 10:e1004447
Qian, Xiaojing; Mruk, Dolores D; Cheng, Yan-Ho et al. (2014) Actin binding proteins, spermatid transport and spermiation. Semin Cell Dev Biol 30:75-85
Wan, H T; Mruk, Dolores D; Tang, Elizabeth I et al. (2014) Role of non-receptor protein tyrosine kinases in spermatid transport during spermatogenesis. Semin Cell Dev Biol 30:65-74
Gungor-Ordueri, N Ece; Tang, Elizabeth I; Celik-Ozenci, Ciler et al. (2014) Ezrin is an actin binding protein that regulates sertoli cell and spermatid adhesion during spermatogenesis. Endocrinology 155:3981-95
Xiao, Xiang; Mruk, Dolores D; Wong, Elissa W P et al. (2014) Differential effects of c-Src and c-Yes on the endocytic vesicle-mediated trafficking events at the Sertoli cell blood-testis barrier: an in vitro study. Am J Physiol Endocrinol Metab 307:E553-62
Gungor-Ordueri, N Ece; Celik-Ozenci, Ciler; Cheng, C Yan (2014) Fascin 1 is an actin filament-bundling protein that regulates ectoplasmic specialization dynamics in the rat testis. Am J Physiol Endocrinol Metab 307:E738-53

Showing the most recent 10 out of 165 publications